134 related articles for article (PubMed ID: 33911004)
1. Detection of microRNA in urine to identify patients with endometrial cancer: a feasibility study.
Donkers H; Hirschfeld M; Weiß D; Erbes T; Jäger M; Pijnenborg J; Bekkers R; Galaal K
Int J Gynecol Cancer; 2021 Jun; 31(6):868-874. PubMed ID: 33911004
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M
Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of microRNA detection in the diagnostics of endometrial cancer.
Donkers H; Hirschfeld M; Weiß D; Erbes T; Jaeger M; Pijnenborg JMA; Bekkers R; Galaal K;
Acta Obstet Gynecol Scand; 2021 Jun; 100(6):1148-1154. PubMed ID: 33705566
[TBL] [Abstract][Full Text] [Related]
4. Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.
Zavesky L; Jandakova E; Turyna R; Langmeierova L; Weinberger V; Minar L
Neoplasma; 2016; 63(1):121-32. PubMed ID: 26639242
[TBL] [Abstract][Full Text] [Related]
5. Identification of Endometrial Cancer-Specific microRNA Biomarkers in Endometrial Fluid.
Yang J; Barkley JE; Bhattarai B; Firouzi K; Monk BJ; Coonrod DV; Zenhausern F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240034
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of microRNA panel in endometrial cancer: A systematic review.
Donkers H; Bekkers R; Galaal K
Oncotarget; 2020 May; 11(21):2010-2023. PubMed ID: 32523655
[TBL] [Abstract][Full Text] [Related]
8. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer.
Wilczynski M; Danielska J; Domanska-Senderowska D; Dzieniecka M; Szymanska B; Malinowski A
Acta Obstet Gynecol Scand; 2018 May; 97(5):560-569. PubMed ID: 29355888
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Value of MicroRNA 21 in Endometrial Cancer and Benign Lesions and its Differential Expression with Clinicopathological Parameters.
Bouziyane A; Lamsisi M; Benaguida H; Benhessou M; El Kerroumi M; Ennaji MM
Microrna; 2021; 10(2):146-152. PubMed ID: 34086554
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of miR-205 in endometrial cancer.
Karaayvaz M; Zhang C; Liang S; Shroyer KR; Ju J
PLoS One; 2012; 7(4):e35158. PubMed ID: 22514717
[TBL] [Abstract][Full Text] [Related]
11. A urinary microRNA (miR) signature for diagnosis of bladder cancer.
Hofbauer SL; de Martino M; Lucca I; Haitel A; Susani M; Shariat SF; Klatte T
Urol Oncol; 2018 Dec; 36(12):531.e1-531.e8. PubMed ID: 30322728
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.
Pospisilova S; Pazourkova E; Horinek A; Brisuda A; Svobodova I; Soukup V; Hrbacek J; Capoun O; Hanus T; Mares J; Korabecna M; Babjuk M
Neoplasma; 2016; 63(5):799-808. PubMed ID: 27468885
[TBL] [Abstract][Full Text] [Related]
13. Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer.
Hanžek A; Siatka C; Duc AE
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7981-7993. PubMed ID: 36914786
[TBL] [Abstract][Full Text] [Related]
14. Expression of microRNAs in the urine of patients with bladder cancer.
Wang G; Chan ES; Kwan BC; Li PK; Yip SK; Szeto CC; Ng CF
Clin Genitourin Cancer; 2012 Jun; 10(2):106-13. PubMed ID: 22386240
[TBL] [Abstract][Full Text] [Related]
15. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.
Fredsøe J; Rasmussen AKI; Thomsen AR; Mouritzen P; Høyer S; Borre M; Ørntoft TF; Sørensen KD
Eur Urol Focus; 2018 Dec; 4(6):825-833. PubMed ID: 28753866
[TBL] [Abstract][Full Text] [Related]
17. PTEN negative correlates with miR-181a in tumour tissues of non-obese endometrial cancer patients.
Geletina NS; Kobelev VS; Babayants EV; Feng L; Pustylnyak VO; Gulyaeva LF
Gene; 2018 May; 655():20-24. PubMed ID: 29477866
[TBL] [Abstract][Full Text] [Related]
18. The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.
Park YA; Lee JW; Choi JJ; Jeon HK; Cho Y; Choi C; Kim TJ; Lee NW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):125-33. PubMed ID: 22015043
[TBL] [Abstract][Full Text] [Related]
19. Verification of microRNA expression in human endometrial adenocarcinoma.
Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K
BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples.
Kent MS; Zwingenberger A; Westropp JL; Barrett LE; Durbin-Johnson BP; Ghosh P; Vinall RL
BMC Vet Res; 2017 Nov; 13(1):339. PubMed ID: 29141625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
